Within Bertin Pharma Branch,
Ellipse Pharmaceuticals provides SMART Innovation & Pharmaceutical Development Services for New Chemical Entities and Biotech-derived drugs. Our services include
Preformulation and
Formulation of new therapeutic actives adapted to the clinical development stage,
Generic or Generic Plus formulations,
Life Cycle Management strategies, Process
troubleshooting and manufacturing
technical assistance.
Ellipse Pharmaceuticals has developed specific expertise and know-how in the following: Modified release formulations including Multiple units systems, Parenteral formulations (IR, SR – liquid & freeze-dried), micro/nano-emulsion systems, patented formulations for mucosal application.
Biotec Centre joins Bertin Pharma Branch
|
Biotec Centre becomes a new member of Bertin Pharma Branch.
Biotec Centre significantly strengthens
SPI-Bio's expertise and competencies in bio-analysis, pharmacokinetics and metabolism by:
- increasing by two its bio-analytic park and
- offering a package service which combines in vivo and in vitro models (models and means proposed in collaboration with the French CEA).
With two GLP compliant facilities, the Bertin Pharma Branch can now undertake the entire range of tests for the assessment of both new chemical entities and products from the biotechnologies.
This team permits to reinforce
Ellipse Pharmaceuticals's expertise in the field of biopharmacy.
Bertin Pharma, with a current turnover over 10 M€ for 80 people, proposes to its clients both flexibility, technical and scientific expertise thanks to a wider equipment platform associated with pluridisciplinary and complementary teams.
